A newly generated neuronal cell model of CLN7 disease reveals aberrant lysosome motility and impaired cell survival
- 1 February 2019
- journal article
- research article
- Published by Elsevier in Molecular Genetics and Metabolism
- Vol. 126 (2) , 196-205
Abstract
No abstract availableKeywords
Funding Information
- Horizon 2020 (666918)
- German Federal Ministry of Education and Research (031A314)
- Deutsche Forschungsgemeinschaft (GRK1459)
This publication has 53 references indexed in Scilit:
- Transcription factor EB (TFEB) is a new therapeutic target for Pompe diseaseEMBO Molecular Medicine, 2013
- Axonal degeneration as a therapeutic target in the CNSCell and tissue research, 2012
- Autophagosomes initiate distally and mature during transport toward the cell soma in primary neuronsJournal of Cell Biology, 2012
- Transcriptional Activation of Lysosomal Exocytosis Promotes Cellular ClearanceDevelopmental Cell, 2011
- Lysosomal positioning coordinates cellular nutrient responsesNature Cell Biology, 2011
- Expression and lysosomal targeting of CLN7, a major facilitator superfamily transporter associated with variant late-infantile neuronal ceroid lipofuscinosisHuman Molecular Genetics, 2010
- Termination of autophagy and reformation of lysosomes regulated by mTORNature, 2010
- Cultures of Cerebellar Granule NeuronsCold Spring Harbor Protocols, 2008
- The Novel Neuronal Ceroid Lipofuscinosis Gene MFSD8 Encodes a Putative Lysosomal TransporterThe American Journal of Human Genetics, 2007
- Lysosomes Behave as Ca2+-regulated Exocytic Vesicles in Fibroblasts and Epithelial CellsJournal of Cell Biology, 1997